Neurophysiology | Varsity Tutors

SECTION 1

Historical Context & Motivation

The study of neurophysiology — the branch of physiology concerned with the function of the nervous system — arose from centuries of inquiry into how living organisms sense, process, and respond to their environment. Early anatomists recognized that nerves connected the brain to the periphery, but the nature of the signal traveling along those nerves remained mysterious until the advent of electrophysiological techniques. The clinical relevance of neurophysiology cannot be overstated: from understanding the mechanism of local anesthetics to diagnosing epilepsy or demyelinating disease, every aspect of clinical neuroscience rests on the principles of neural signaling.

The progression from anatomical description to quantitative biophysics unfolded over roughly two centuries, driven by key discoveries in electricity, membrane biology, and ion channel physiology. Each milestone below represents a conceptual leap that shaped the modern understanding of how neurons generate and transmit information — knowledge you will apply repeatedly on USMLE Step 1 and throughout clinical practice.

1791

Galvani's Animal Electricity

Luigi Galvani demonstrated that frog leg muscles contracted in response to electrical stimulation, providing the first evidence that nerves conduct electrical signals — a phenomenon he termed animal electricity.

1850

Helmholtz Measures Nerve Conduction Velocity

Hermann von Helmholtz measured the speed of the nerve impulse in frog motor neurons at approximately 27 m/s, disproving the prevailing notion that neural transmission was instantaneous.

1902

Bernstein's Membrane Theory

Julius Bernstein proposed that the resting potential arises from selective membrane permeability to potassium ions, laying the theoretical groundwork for the ionic basis of nerve function.

1952

Hodgkin–Huxley Model

Alan Hodgkin and Andrew Huxley published their Nobel Prize–winning quantitative model of the action potential in the squid giant axon, describing voltage-gated Na⁺ and K⁺ conductances with mathematical precision.

1976

Neher & Sakmann — Patch Clamp

Erwin Neher and Bert Sakmann developed the patch-clamp technique, allowing recording of currents through single ion channels and revolutionizing our understanding of channel pharmacology — essential knowledge for drug mechanism questions on board exams.

The central question that emerges from this historical arc is deceptively simple: How does an electrochemical gradient across a lipid bilayer give rise to rapid, long-distance communication in the nervous system? Answering this question requires integrating concepts from membrane biophysics, ion channel physiology, and synaptic transmission — all of which converge in the sections that follow.

SECTION 2

Core Principles of Neural Signaling

Neurophysiology at its foundation rests on a set of interrelated principles that govern how neurons establish, maintain, and rapidly alter electrical potentials across their membranes. These principles are not merely academic; they appear in board-style questions on topics ranging from the mechanism of hyperkalemia-induced cardiac arrest to the pharmacology of benzodiazepines. Mastering the following five concepts provides the scaffolding on which all of clinical neuroscience is built.

Resting Membrane Potential

The voltage difference (approximately −70 mV) across the neuronal membrane at rest, maintained primarily by K⁺ leak channels and the Na⁺/K⁺-ATPase. This is the baseline from which all signaling events depart.

Electrochemical Gradients

Each ion species is subject to two forces — the concentration gradient (chemical) and the electrical gradient (voltage). The balance point for a given ion is described by its equilibrium potential (E_ion).

Voltage-Gated Ion Channels

Protein pores that open and close in response to membrane voltage changes. Na⁺ channels drive depolarization; K⁺ channels drive repolarization. Channel kinetics define the shape and duration of the action potential.

Action Potential Propagation

Once threshold is reached (≈ −55 mV), an all-or-none action potential propagates unidirectionally along the axon. In myelinated fibers, saltatory conduction dramatically increases velocity — a concept tested frequently in the context of demyelinating diseases.

Synaptic Transmission

At the synapse, the electrical signal is transduced into a chemical signal (neurotransmitter release) and back. Ca²⁺ influx at the presynaptic terminal triggers vesicle fusion; postsynaptic receptor activation generates excitatory or inhibitory potentials.

✦ KEY TAKEAWAY

Think of the neuron as a rechargeable battery. The Na⁺/K⁺-ATPase is the charger, continuously pumping ions to maintain the charge separation (resting potential). When the neuron fires, it is like briefly short-circuiting the battery — ions rush through voltage-gated channels, rapidly discharging and then recharging the membrane. The synapse is the USB cable connecting one battery to the next device: the electrical energy is converted into a chemical packet (neurotransmitter) that jumps the gap and energizes the downstream neuron.

SECTION 3

The Action Potential — Visual Explanation

The action potential is the fundamental unit of neural signaling — a transient, self-propagating reversal of membrane polarity that travels along the axon without decrement. Understanding its phases is essential for interpreting how local anesthetics block Na⁺ channels, why refractory periods limit firing frequency, and how electrolyte imbalances (e.g., hypokalemia, hyperkalemia) alter cardiac and neural excitability. The diagram below traces the membrane potential through each phase of the action potential, mapping the corresponding ion channel events.

The action potential trace (cyan line) shows the membrane potential over time. Phase ① represents the resting state at −70 mV. Phase ② (depolarization) occurs as voltage-gated Na⁺ channels open and Na⁺ rushes into the cell, driving the potential toward +30 mV. Phase ③ (repolarization) follows Na⁺ channel inactivation and delayed K⁺ channel opening. Phase ④ (hyperpolarization) represents the undershoot below resting potential due to sustained K⁺ efflux.

Clinically, each phase of the action potential represents a potential drug target. Local anesthetics (e.g., lidocaine) block voltage-gated Na⁺ channels during the depolarization phase, preventing action potential initiation. Class III antiarrhythmics (e.g., amiodarone) prolong repolarization by blocking K⁺ channels, extending the refractory period. Understanding which phase is affected allows you to predict both therapeutic effects and toxicity profiles — a recurring theme on Step 1.

SECTION 4

Mathematical Framework — The Nernst & Goldman Equations

The quantitative backbone of neurophysiology is built on two equations that relate ion concentrations and membrane permeabilities to electrical potential. The Nernst equation calculates the equilibrium potential for a single ion species, while the Goldman-Hodgkin-Katz (GHK) equation integrates multiple ion permeabilities to predict the actual resting membrane potential. Both equations are high-yield for USMLE Step 1, particularly in clinical vignettes involving electrolyte disturbances.

NERNST EQUATION

E_ion = (RT / zF) × ln([ion]_outside / [ion]_inside)

Where E_ion = equilibrium potential (mV), R = gas constant (8.314 J/mol·K), T = temperature in Kelvin (310 K at body temperature), z = valence of the ion, F = Faraday constant (96,485 C/mol). At 37°C for a monovalent cation, this simplifies to E = (61.5 mV / z) × log₁₀([ion]_out / [ion]_in).

GOLDMAN-HODGKIN-KATZ EQUATION

V_m = (RT/F) × ln( (P_K[K⁺]_o + P_Na[Na⁺]_o + P_Cl[Cl⁻]_i) / (P_K[K⁺]_i + P_Na[Na⁺]_i + P_Cl[Cl⁻]_o) )

Where V_m = resting membrane potential, P = relative permeability of each ion. Note that Cl⁻ concentrations are inverted (inside/outside) because of its negative valence. At rest, P_K >> P_Na, so V_m is closer to E_K (−90 mV) than to E_Na (+60 mV).

Typical ion concentrations across a mammalian neuronal membrane at 37°C

Ion	Intracellular (mM)	Extracellular (mM)	E_ion (mV)
K⁺	140	4	−94
Na⁺	14	140	+61
Cl⁻	4	105	−89
Ca²⁺	0.0001	2.5	+136

⚠️ HIGH-YIELD CLINICAL CORRELATION

In hyperkalemia, extracellular K⁺ rises, reducing the K⁺ concentration gradient. By the Nernst equation, E_K becomes less negative, which depolarizes the resting membrane potential. Initially this increases excitability (peaked T waves on ECG), but sustained depolarization inactivates Na⁺ channels, leading to decreased excitability, widened QRS, and risk of fatal arrhythmia.

SECTION 5

Synaptic Transmission — Detailed Breakdown

Once the action potential reaches the axon terminal, the electrical signal must be converted into a chemical signal to cross the synaptic cleft — a gap of approximately 20–40 nm between the presynaptic and postsynaptic membranes. This process of synaptic transmission is the primary target of a vast array of pharmacological agents tested on USMLE Step 1, from acetylcholinesterase inhibitors used in myasthenia gravis to SSRIs used in depression. The sequence of events is highly conserved across both the central and peripheral nervous systems and proceeds through a series of well-characterized molecular steps.

The diagram illustrates the major components of a chemical synapse. Synaptic vesicles (yellow) store neurotransmitter in the presynaptic terminal. When the action potential opens voltage-gated Ca²⁺ channels, calcium influx triggers SNARE-mediated vesicle fusion and neurotransmitter release into the synaptic cleft. Postsynaptic receptors include ionotropic (fast, ligand-gated) and metabotropic (slow, G-protein coupled) types. Signal termination occurs via reuptake or enzymatic degradation.

Step 1 — Action potential arrival: Depolarization reaches the presynaptic terminal, opening voltage-gated Ca²⁺ channels.
Step 2 — Ca²⁺ influx: Calcium enters the terminal down its enormous electrochemical gradient (E_Ca ≈ +136 mV). This is the critical coupling step between electrical and chemical signaling.
Step 3 — Vesicle fusion: Ca²⁺ binds synaptotagmin on the vesicle membrane, triggering SNARE-complex–mediated fusion and exocytosis of neurotransmitter. Botulinum toxin cleaves SNARE proteins, blocking this step.
Step 4 — Receptor binding: Neurotransmitter diffuses across the cleft and binds postsynaptic receptors, generating either EPSPs (excitatory) or IPSPs (inhibitory).
Step 5 — Signal termination: Neurotransmitter is removed by enzymatic degradation (e.g., AChE at the NMJ), reuptake transporters (e.g., SERT for serotonin), or diffusion. SSRIs inhibit serotonin reuptake, increasing synaptic serotonin levels.

SECTION 6

Worked Example — Calculating Equilibrium Potential

The following worked example walks through the calculation of the potassium equilibrium potential using the Nernst equation — a problem type that appears frequently on USMLE Step 1, often embedded in clinical vignettes about electrolyte abnormalities.

Nernst Equation — Potassium Equilibrium Potential in Hyperkalemia

Step 1 — Identify Given ValuesA patient presents with serum K⁺ of 7.0 mM (normal ≈ 4.0 mM). Intracellular K⁺ remains approximately 140 mM. Body temperature is 37°C (310 K). Potassium has a valence of z = +1. We will use the simplified Nernst equation at 37°C: E_K = (61.5 mV / z) × log₁₀([K⁺]_out / [K⁺]_in).

[K⁺]_out = 7.0 mM, [K⁺]_in = 140 mM, z = +1

Step 2 — Calculate the Concentration RatioRatio = [K⁺]_out / [K⁺]_in = 7.0 / 140 = 0.05.

Ratio = 0.05

Step 3 — Take the Logarithmlog₁₀(0.05) = log₁₀(5 × 10⁻²) = log₁₀(5) + log₁₀(10⁻²) ≈ 0.699 + (−2) = −1.301.

log₁₀(0.05) ≈ −1.301

Step 4 — Apply the Nernst EquationE_K = (61.5 mV / 1) × (−1.301) = −80.0 mV.

E_K ≈ −80 mV (hyperkalemia)

Step 5 — Interpret ClinicallyCompare to the normal E_K ≈ −94 mV (when [K⁺]_out = 4 mM). In hyperkalemia, E_K shifts from −94 mV to −80 mV (becomes less negative). Since the resting membrane potential closely follows E_K, the cell depolarizes — moving V_m closer to threshold. This explains the initial increased excitability (peaked T waves) and, if sustained, the paradoxical decrease in excitability from Na⁺ channel inactivation (widened QRS, risk of cardiac arrest).

Clinical: Hyperkalemia depolarizes the resting membrane potential, causing characteristic ECG changes and arrhythmia risk.

SECTION 7

Major Neurotransmitter Systems — Comparison

USMLE Step 1 questions frequently test your ability to associate specific neurotransmitter systems with their anatomical pathways, receptor subtypes, clinical syndromes, and pharmacological targets. The following comparison table consolidates the highest-yield neurotransmitter facts, organized by chemical class. It is worth noting that no single neurotransmitter operates in isolation — neural circuits integrate multiple transmitter systems, and many psychiatric and neurological drugs affect multiple pathways simultaneously.

High-yield neurotransmitter comparison for USMLE Step 1

Neurotransmitter	Type	Key Receptors	Major Pathways / Functions	Clinical Relevance
ACh	Small molecule (amine)	Nicotinic (ionotropic); Muscarinic M₁–M₅ (metabotropic)	NMJ, autonomic ganglia, parasympathetic postganglionic, basal forebrain → cortex	Myasthenia gravis (anti-nAChR Ab), Alzheimer's (↓ ACh), organophosphate poisoning
Norepinephrine	Catecholamine	α₁, α₂, β₁, β₂, β₃ (all metabotropic/GPCRs)	Locus coeruleus → cortex; sympathetic postganglionic	Depression (monoamine hypothesis), pheochromocytoma, shock management (vasopressors)
Dopamine	Catecholamine	D₁-like (D₁, D₅), D₂-like (D₂, D₃, D₄)	Nigrostriatal (motor), mesolimbic (reward), mesocortical, tuberoinfundibular	Parkinson's (↓ nigrostriatal DA), schizophrenia (↑ mesolimbic DA), antipsychotic side effects
Serotonin (5-HT)	Indolamine	5-HT₁–₇ (mostly metabotropic); 5-HT₃ is ionotropic	Raphe nuclei → widespread CNS; mood, sleep, appetite, nausea	Depression (SSRIs), serotonin syndrome, carcinoid syndrome, migraine (triptans)
GABA	Amino acid (inhibitory)	GABA-A (ionotropic, Cl⁻ channel); GABA-B (metabotropic)	Main inhibitory NT in CNS; widespread interneurons	Epilepsy (↓ GABAergic tone), benzodiazepines & barbiturates (↑ GABA-A), hepatic encephalopathy
Glutamate	Amino acid (excitatory)	NMDA, AMPA, kainate (ionotropic); mGluR (metabotropic)	Main excitatory NT in CNS; learning, memory (LTP), excitotoxicity	Excitotoxicity in stroke/TBI, memantine for Alzheimer's (NMDA antagonist)

✦ KEY TAKEAWAY

Think of the neurotransmitter systems as different communication channels within a large corporation. Glutamate is the company-wide email blast — excitatory and pervasive. GABA is the compliance officer, applying brakes to prevent reckless activity. Dopamine is the incentive program — it modulates motivation and reward. When you encounter a pharmacology question, ask: which channel is the drug amplifying or silencing, and what happens when that balance shifts?

SECTION 8

Connecting Basic Neurophysiology to Advanced Clinical Neuroscience

The principles covered in this lesson — resting potential, action potential generation, synaptic transmission — form the foundation upon which more complex neurological phenomena and clinical conditions are understood. Step 1 questions frequently bridge basic science and clinical medicine by requiring you to trace a pathologic process back to its biophysical origin. Below, we compare the foundational neurophysiological concepts with their advanced clinical extensions, highlighting how mastering the basics empowers rapid clinical reasoning.

Basic neurophysiology → advanced clinical correlation

Basic Concept	Advanced Clinical Extension	Example Board Question Theme
Nernst / GHK equations	Electrolyte disturbances altering cardiac/neural excitability	Patient with renal failure and peaked T waves — what is the biophysical mechanism?
Voltage-gated Na⁺ channel kinetics	Local anesthetic mechanism, epilepsy pharmacotherapy (carbamazepine, phenytoin)	Lidocaine preferentially blocks inactivated Na⁺ channels — use-dependent blockade
Saltatory conduction / myelination	Multiple sclerosis, Guillain-Barré syndrome	Patient with ascending weakness post-viral illness — identify demyelinating pathology
Ca²⁺-dependent neurotransmitter release	Lambert-Eaton syndrome (anti-VGCC Ab), botulism (SNARE cleavage)	Proximal weakness improving with repeated use — which presynaptic target?
GABA-A receptor pharmacology	Benzodiazepine overdose (flumazenil reversal), status epilepticus management	Mechanism difference: BDZ ↑ frequency vs. barbiturate ↑ duration of Cl⁻ channel opening
Glutamate excitotoxicity	Ischemic penumbra in stroke, memantine in Alzheimer's disease	Why does ischemia lead to excessive glutamate release and neuronal death?

As you advance through the neuroscience curriculum and into clinical rotations, you will find that virtually every neurological exam finding — from absent reflexes to nystagmus — can be understood by tracing the signal pathway from receptor to effector and identifying where the chain is broken. The biophysical principles you have learned here are not abstractions; they are the operating system on which clinical neuroscience runs.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

At rest, the neuronal membrane is most permeable to which ion, and how does this explain why the resting membrane potential (≈ −70 mV) is closer to E_K than to E_Na?

PROBLEM 2 — BASIC CALCULATION

Using the simplified Nernst equation at 37°C (E = 61.5/z × log₁₀[ion]_out/[ion]_in), calculate the equilibrium potential for Na⁺ given [Na⁺]_out = 140 mM and [Na⁺]_in = 14 mM.

PROBLEM 3 — INTERMEDIATE

A patient receives a medication that selectively blocks voltage-gated K⁺ channels. Predict the effect on: (a) action potential duration, (b) the absolute refractory period, and (c) the relative refractory period. Explain the biophysical reasoning for each.

PROBLEM 4 — APPLIED

A 35-year-old woman presents with ptosis and diplopia that worsen throughout the day. Repetitive nerve stimulation shows a decremental response in compound muscle action potential amplitude. Antibodies against the postsynaptic nicotinic acetylcholine receptor are detected. Using your knowledge of synaptic transmission, explain: (a) why repeated stimulation produces a decremental response, and (b) why acetylcholinesterase inhibitors (e.g., pyridostigmine) improve symptoms.

PROBLEM 5 — CRITICAL THINKING

Lambert-Eaton myasthenic syndrome (LEMS) and myasthenia gravis (MG) both cause weakness, but they differ in their pathophysiology, electrophysiological findings, and clinical patterns. Using your understanding of presynaptic versus postsynaptic targets, compare and contrast these two conditions with respect to: (a) the target of the autoantibodies, (b) the expected response to repetitive nerve stimulation, (c) the effect of repeated voluntary muscle use, and (d) autonomic dysfunction.

SUMMARY

Neurophysiology — Summary Review

Neurophysiology governs every aspect of neural communication. The resting membrane potential (≈ −70 mV) is established by the Na⁺/K⁺-ATPase and K⁺ leak channels, quantified by the Nernst equation (single ion) and Goldman-Hodgkin-Katz equation (multiple ions). The action potential is an all-or-none, self-propagating depolarization driven by the sequential activation and inactivation of voltage-gated Na⁺ channels (depolarization) and voltage-gated K⁺ channels (repolarization), with propagation velocity enhanced by myelination and saltatory conduction.

At the synapse, Ca²⁺ influx through presynaptic voltage-gated Ca²⁺ channels triggers SNARE-mediated vesicle fusion and neurotransmitter release. Postsynaptic responses depend on receptor type: ionotropic receptors (fast, direct ion channel gating) versus metabotropic receptors (slow, G-protein–coupled signaling). Major neurotransmitters — ACh, NE, DA, 5-HT, GABA, and glutamate — each have distinct synthetic pathways, receptor families, and clinical disease associations that are core content for USMLE Step 1. Signal termination occurs through enzymatic degradation or reuptake, both of which are major pharmacological targets.